3billion visited Mexico City for rare disease diagnostic collaboration

Mexico City, Mexico – 3billion recently visited major hospitals and research institutions in Mexico City to conduct seminars and meetings aimed at fostering collaboration among medical professionals. During the visit, the company held seminars on rare disease genetic testing and diagnosis at the Children’s Hospital of Mexico Federico Gomez and the National Institute of Pediatrics (INP), two of the most active treatment and research institutions in Mexico.

In addition, 3billion also held discussions on research collaboration with the XXI Century National Medical Center, managed by the Mexican Institute of Social Security (IMSS) and the National Institute of Genomic Medicine (INMEGEN). The company aims to improve the rare disease diagnosis process in Mexico and provide better services to diagnose rare disease patients in Central and South America.

“Our visit to Mexico City was a great opportunity to engage with medical professionals and institutions in the region,” said a spokesperson for 3billion. “We believe that through collaboration and knowledge-sharing, we can make a significant impact in the diagnosis and treatment of rare diseases in Mexico and beyond.”